Altria (MO) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

24.04.25 15:15 Uhr

Werte in diesem Artikel
Aktien

53,99 EUR 0,75 EUR 1,41%

Indizes

PKT PKT

16.419,4 PKT -134,4 PKT -0,81%

2.722,2 PKT 11,0 PKT 0,41%

5.631,3 PKT 24,4 PKT 0,43%

Wall Street analysts forecast that Altria (MO) will report quarterly earnings of $1.17 per share in its upcoming release, pointing to a year-over-year increase of 1.7%. It is anticipated that revenues will amount to $4.64 billion, exhibiting a decline of 1.7% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 1.9% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.Given this perspective, it's time to examine the average forecasts of specific Altria metrics that are routinely monitored and predicted by Wall Street analysts.The combined assessment of analysts suggests that 'Net revenue- All Other/ Financial Services' will likely reach $36.00 million. The estimate indicates a change of +89.5% from the prior-year quarter.The collective assessment of analysts points to an estimated 'Revenues net of excise taxes- Oral tobacco products' of $633.90 million. The estimate indicates a year-over-year change of +1.3%.The average prediction of analysts places 'Revenues net of excise taxes- Smokeable Products' at $3.97 billion. The estimate indicates a change of -2.6% from the prior-year quarter.According to the collective judgment of analysts, 'Operating Income (Loss)/ Reported OCI- Oral tobacco products' should come in at $448.82 million. Compared to the current estimate, the company reported $435 million in the same quarter of the previous year.Analysts predict that the 'Adjusted OCI- Smokeable Products' will reach $2.48 billion. The estimate compares to the year-ago value of $2.45 billion.View all Key Company Metrics for Altria here>>>Shares of Altria have experienced a change of +1.4% in the past month compared to the -5.1% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), MO is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Altria Group, Inc. (MO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Altria und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Altria

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Altria

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Altria Inc.

Wer­bung

Analysen zu Altria Inc.

DatumRatingAnalyst
02.04.2020Altria HoldJefferies & Company Inc.
12.07.2019Altria buyGoldman Sachs Group Inc.
31.07.2017Altria NeutralUBS AG
31.07.2017Altria BuyStifel, Nicolaus & Co., Inc.
31.07.2017Altria Sector PerformRBC Capital Markets
DatumRatingAnalyst
12.07.2019Altria buyGoldman Sachs Group Inc.
31.07.2017Altria BuyStifel, Nicolaus & Co., Inc.
27.06.2016Altria Group BuyStifel, Nicolaus & Co., Inc.
02.02.2015Altria Group BuyStifel, Nicolaus & Co., Inc.
31.10.2014Altria Group BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
02.04.2020Altria HoldJefferies & Company Inc.
31.07.2017Altria NeutralUBS AG
31.07.2017Altria Sector PerformRBC Capital Markets
09.08.2012Altria Group neutralCitigroup Corp.
26.07.2012Altria Group neutralUBS AG
DatumRatingAnalyst
23.03.2017Altria Group UnderperformRBC Capital Markets
27.04.2005Update UST Inc.: UnderperformGoldman Sachs
27.04.2005UST: UnderweightJP Morgan
24.01.2005UST: UnderweightJP Morgan

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Altria Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen